Fresh Equities
ASX:ACL

ASX:ACL

ALCHEMIA LIMITED

ALCHEMIA LIMITED has not announced any current capital raises, but we are collecting interest for future raises.

Demand Registered for Next Raise
< $50k
Investors Interested in Next Raise
< 10
How Fresh Equities Works
Authentication

1. Create Account

Complete your onboarding digitally in less than 3 minutes.

Authentication

2. View Terms

View the full term sheet for the capital raise.

Authentication

3. Bid for Allocation

Submit and track your bid online.

Capital Raise History

Loading...


Company Overview

Alchemia Limited (ACL) is a biotechnology company which develops new human therapeutics based on its proprietary drug discovery and expands drug targeting and synthesis technologies in Australia and USA. Former Names --

Type

Listed Company

GICS Sub-industry

Biotechnology

Head Office

Level 4/100 Albert Rd, South Melbourne VIC 3205, Australia

Biotechnology
Health Care
Biotech & Health

Price Chart


Quarterly Cash Flows

The numbers below are derived from quarterly cash flow reports provided by the company. Fresh Equities does not guarantee that the information provided is accurate, you can read the associated report by clicking read more for the quarter. Always do your own research and do not rely on the information provided here as your only source of research.

Loading...


Directors


Announcements

All
All Time
    Final Director's Interest Notices x2 on 8 October 2019

    Shareholder Details

    Change of Director's Interest Notice on 8 October 2019

    Shareholder Details

    Initial Director's Interest Notice x3 on 8 October 2019

    Shareholder Details

    Becoming a substantial holder on 4 October 2019

    Shareholder Details

    Becoming a substantial holder on 4 October 2019

    Shareholder Details

    Becoming a substantial holder on 4 October 2019

    Shareholder Details

    Becoming a substantial holder on 4 October 2019

    Shareholder Details

    Appendix 3B on 3 October 2019

    Issued Capital

  • Completion of Acquisition and Capital Raising on 2 October 2019

    Issued Capital

  • Completion of Share Consolidation on 26 September 2019

    Issued Capital

    Load More

News

Loading...